Reports
Sale
Global Drug Screening Market Size, Trends, Growth, Analysis, Forecast: By Product and Services: Drug Screening Services, Drug Screening Products, Rapid Testing Devices (RTD), Oral Fluid Testing Devices, Consumables; By End User: Workplace and Schools, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Drug Screening Market Outlook
The global drug screening market value was USD 7 billion in 2023, driven by the increasing prevalence of drug abuse across the globe. The market size is anticipated to grow at a CAGR of 13.8% during the forecast period of 2024-2032 to achieve a value of USD 22.5 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to be a Significant Regional Market for Drug Screening
North America is anticipated to be the largest regional market for drug screening. The dominance of the North American market can be ascribed to factors such as rising illicit drug usage, government funding available to combat drug abuse, regulations supporting drug screening, the rising incidence of accidents caused by alcohol impairment, and the presence of key players in the region. Also, various initiatives are being implemented by the United States government to monitor the symptoms and determine whether a person is under drug abuse. For example, the Patients and Communities Act of 2018 was enacted by the government of the United States to combat drug usage. As a result, increased drug and alcohol addiction and strict rules to detect intoxication in the body are likely to aid the market growth in the region over the forecast period. The increasing cases of accidents caused by drunk driving is another major factor expected to contribute to revenue growth in countries such as the United States over the forecast period.
Urine Samples Segment to Hold the Largest Market Share
Based on the sample type, the urine samples segment revenue is expected to expand at a rapid rate in the drug screening market throughout the forecast period as drug presence can be easily detected and is painless compared to a blood sample. Urine is the most commonly utilised for testing drug abuse, and it is a simple sample to analyse. The benefits it offers, such as cost-effectiveness, the high detection accuracy of multiple drugs and instant results, are further driving the growth of the market. Urine drug testing is a critical aspect of monitoring patients on long-term opioid therapy and has also been recommended for patients on a long-term benzodiazepine or stimulant therapy. Also, it is one of the crucial tests to check opioid dependency. Thus, the rising prevalence of opioid overdose is expected to drive market growth over the forecast period.
Market Segmentations
Drug screening is a technique for detecting illegal and prescription drugs in blood, urine, and other bodily fluids. Potential medications are found and optimised using this process before a candidate drug is chosen for clinical trials. In high-throughput screening tests, huge libraries of compounds are screened for a specific biological activity.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on products and services, the market includes:
- Drug Screening Product
- Analytical Instruments
- Rapid Testing Devices
- Oral Fluid Testing Devices
- Consumables
- Drug Screening Service
By sample type, the market is divided into:
- Urine Samples
- Breath Samples
- Oral Fluid Samples
- Hair Samples
- Other
The end-users of the market are:
- Drug Testing Laboratories
- Workplaces
- Criminal Justice and Law Enforcement Agencies
- Hospitals
- Drug Treatment Centres
- Individual Users
- Pain Management Centres
- Schools and Colleges
The regional markets for the drug screening market can be divided into North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Consumption of Drug and Alcohol Augmenting the Market Growth
The growth in the global drug screening market can be attributed to the growing drug and alcohol consumption, increasing road accidents due to overdose of drugs while driving, rising regulatory approvals for drug screening products and services, illegal alcohol use by teens, and prescription drug misuse. The development of advanced screening devices and growing awareness regarding the benefits of alcohol or drug screening in the workplace creates new opportunities for key players in the market. For example, advanced drug-testing processes can be used in the workplace to identify illicit narcotics in sweat molecules and saliva using fingerprint tests and mouth swabs. The "lab-on-a-chip" technology can identify amphetamines, MDMA, cocaine, and opiates, among other drugs.
In addition, rising government measures to counter drug misuse, an increase in clinical studies, and the enforcement of strict laws and regulations demanding alcohol and drug testing in public safety services are likely to boost the drug screening market’s growth over the forecast period. Furthermore, the screening is easy to implement, thus offering flexible and effective workplace drug testing, which is also expected to fuel market growth.
Key Players in the Global Drug Screening Market
The report gives a detailed analysis of the following key players in the global drug screening market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Laboratory Corporation of America® Holdings.
- Quest Diagnostics
- Abbott Laboratories
- Thermo Fisher Scientific Inc.
- Alfa Scientific Designs Inc.
- OraSure Technologies, Inc.
- F. Hoffmann-La Roche Ltd
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Products and Services |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Drug Screening Market Overview
3.1 Global Drug Screening Market Historical Value (2017-2023)
3.2 Global Drug Screening Market Forecast Value (2024-2032)
4 Global Drug Screening Market Landscape
4.1 Global Drug Screening Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Drug Screening Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by End User
4.2.3 Analysis by Region
5 Global Drug Screening Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Drug Screening Market Segmentation
6.1 Global Drug Screening Market, by Product and Services
6.1.1 Market Overview
6.1.2 Drug Screening Services
6.1.3 Drug Screening Products
6.1.3.1 Analytical Instruments
6.1.3.1.1 Breathalyzers
6.1.3.1.1.1 Law Enforcement Agencies Breathalyzers
6.1.3.1.1.2 Fuel Cell Breathalyzers
6.1.3.1.1.3 Semi-Conductor Breathalyzers
6.1.3.1.1.4 Others
6.1.3.2 Immunoassay Analyzers
6.1.3.3 Chromatography Instruments
6.1.4 Rapid Testing Devices (RTD)
6.1.4.1 Urine Testing Devices
6.1.4.2 Drug Testing Cups
6.1.4.3 Dip Cards
6.1.4.4 Drug Testing Cassettes
6.1.5 Oral Fluid Testing Devices
6.1.6 Consumables
6.1.6.1 Assay Kits
6.1.6.2 Sample Collection Devices
6.1.6.3 Calibrators & Controllers
6.1.6.4 Others
6.2 Global Drug Screening Market, by End User
6.2.1 Market Overview
6.2.2 Workplace and Schools
6.2.3 Criminal Justice Systems and Law Enforcement Agencies
6.2.4 Drug Testing Laboratories
6.2.5 Drug Treatment Centers
6.2.6 Hospitals
6.2.7 Personal Users
6.2.8 Pain Management Centers
6.2.9 Others
6.3 Global Drug Screening Market by Region
6.3.1 Market Overview
6.3.2 North America
6.3.3 Europe
6.3.4 Asia Pacific
6.3.5 Latin America
6.3.6 Middle East and Africa
7 North America Drug Screening Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Drug Screening Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Drug Screening Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Drug Screening Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Drug Screening Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.2 US FDA
16.3 EU EMA
16.4 INDIA CDSCO
16.5 JAPAN PMDA
16.6 Others
17 Supplier Landscape
17.1 LabCorp
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Quest Diagnostics
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Abbott
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Thermo Fisher Scientific, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Alfa Scientific Designs, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 OraSure Technologies, Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Siemens
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 F. Hoffmann-La Roche Ltd
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 MPD Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Shimadzu Corporation
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Lifeloc Technologies, Inc.
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Drägerwerk AG & Co. KGaA
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Premier Biotech, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Omega Laboratories, Inc.
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Psychemedics Corporation
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
17.16 Clinical Reference Laboratory Inc.,
17.16.1 Financial Analysis
17.16.2 Product Portfolio
17.16.3 Demographic Reach and Achievements
17.16.4 Mergers and Acquisitions
17.16.5 Certifications
17.17 American Bio Medica Corporation
17.17.1 Financial Analysis
17.17.2 Product Portfolio
17.17.3 Demographic Reach and Achievements
17.17.4 Mergers and Acquisitions
17.17.5 Certifications
17.18 ACM Global Laboratories
17.18.1 Financial Analysis
17.18.2 Product Portfolio
17.18.3 Demographic Reach and Achievements
17.18.4 Mergers and Acquisitions
17.18.5 Certifications
17.19 Sciteck, Inc.
17.19.1 Financial Analysis
17.19.2 Product Portfolio
17.19.3 Demographic Reach and Achievements
17.19.4 Mergers and Acquisitions
17.19.5 Certifications
17.20 Synens SAS
17.20.1 Financial Analysis
17.20.2 Product Portfolio
17.20.3 Demographic Reach and Achievements
17.20.4 Mergers and Acquisitions
17.20.5 Certifications
18 Global Drug Screening Market- Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Pricing Models and Strategies (Additional Insight)
21.1 Overview
21.2 Cost Model
21.2.1 Manufacturing Cost Analysis
21.2.2 Procurement Cost Analysis
21.2.3 Clinical Trial Cost Factors
21.3 Pricing Strategies
21.3.1 Competitor Pricing Analysis
21.3.2 Key Assessment of Product Attributes
21.3.3 Pricing Benchmark
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
Drug screening was valued at USD 7 billion in 2023.
The market is expected to grow at a CAGR of 13.8% from 2024 to 2032 to reach USD a value of USD 22.5 billion by 2032.
The major drivers of the market include the rising prevalence of opioid overdose, increasing road accidents due to overdose of drugs while driving, rising regulatory approvals for drug screening products and services, illegal alcohol use by teens, prescription drug misuse, development of advanced screening devices, growing awareness regarding the benefits of alcohol or drug screening in the workplace, and increase in clinical studies.
The growing drug and alcohol consumption and rising government measures to counter drug misuse are the key industry trends propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Based on products and services, the market is divided into drug screening product and drug screening service. Drug screening product is further divided into analytical instruments, rapid testing devices, oral fluid testing devices, and consumables.
Based on sample type, the market is divided into urine samples, breath samples, oral fluid samples, and hair samples, among others.
The end-users of the market include drug testing laboratories, workplaces, criminal justice and law enforcement agencies, hospitals, drug treatment centres, individual users, pain management centres, schools and colleges.
The major players in the market include Laboratory Corporation of America® Holdings., Quest Diagnostics, Abbott Laboratories, Thermo Fisher Scientific Inc., Alfa Scientific Designs Inc., OraSure Technologies, Inc., and F. Hoffmann-La Roche Ltd, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER